A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
暂无分享,去创建一个
B. Pulendran | M. Feinberg | S. Joshi | D. Volkin | Ozan S. Kumru | M. Sanyal | Mengyun Hu | F. Villinger | M. Morris | G. Vasudevan | Shaogeng Tang | N. Friedland | Peter S. Kim | P. Arunachalam | J. Fontenot | C. Hanson | Lisa M. Shirreff | P. Weidenbacher | Ya-Chen Cheng | J. Do | Jonathan Do
[1] B. Gunn,et al. Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers , 2022, Science Translational Medicine.
[2] D. Follmann,et al. A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines. , 2022, The New England journal of medicine.
[3] E. Wood,et al. Monoclonal antibody levels and protection from COVID-19 , 2022, medRxiv.
[4] J. Do,et al. Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development , 2022, Biochemistry.
[5] G. Alter,et al. Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease , 2022, Immunological reviews.
[6] M. Gale,et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity , 2022, Cell.
[7] Mark M. Davis,et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination , 2022, Cell.
[8] Gregory D. Gromowski,et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge , 2021, NPJ vaccines.
[9] Monzurul A. Roni,et al. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines , 2021, Vaccines.
[10] M. Davenport,et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.
[11] B. Pulendran,et al. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity , 2021, Nature.
[12] Rebecca Wang,et al. Accelerating and de‐risking CMC development with transposon‐derived manufacturing cell lines , 2021, Biotechnology and bioengineering.
[13] J. Cohen,et al. Reinfection with SARS-CoV-2: Implications for Vaccines , 2020, Clinical Infectious Diseases.
[14] D. Lauffenburger,et al. Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.
[15] W. Chiu,et al. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice , 2020, bioRxiv.
[16] D. Burton,et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model , 2020, Science.
[17] Ilya J. Finkelstein,et al. Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes , 2020, bioRxiv.
[18] J. Bloom,et al. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays , 2020, bioRxiv.
[19] Philip L. Felgner,et al. A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.
[20] P. Wilson,et al. Harnessing immune history to combat influenza viruses. , 2018, Current opinion in immunology.
[21] R. Kelly,et al. Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System. , 2018, Biotechnology journal.
[22] D. Agard,et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.
[23] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[24] J. Mascola,et al. Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. , 2013, The Journal of infectious diseases.
[25] J. Whittle,et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.
[26] B. Antonsson,et al. Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. , 2012, Journal of biotechnology.
[27] C. Frye,et al. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells , 2012, Biotechnology and bioengineering.
[28] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..